"Mice, Knockout" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
| Descriptor ID |
D018345
|
| MeSH Number(s) |
B01.050.050.136.500.500 B01.050.150.900.649.313.992.635.505.500.550.455 B01.050.150.900.649.313.992.635.505.500.800.500
|
| Concept/Terms |
Mice, Knockout- Mice, Knockout
- Mice, Knock-out
- Knock-out Mice
- Mice, Knock out
- Mouse, Knockout
- Knockout Mouse
- Knockout Mice
|
Below are MeSH descriptors whose meaning is more general than "Mice, Knockout".
Below are MeSH descriptors whose meaning is more specific than "Mice, Knockout".
This graph shows the total number of publications written about "Mice, Knockout" by people in this website by year, and whether "Mice, Knockout" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 7 | 7 |
| 1997 | 1 | 4 | 5 |
| 1998 | 0 | 9 | 9 |
| 1999 | 0 | 17 | 17 |
| 2000 | 0 | 22 | 22 |
| 2001 | 0 | 20 | 20 |
| 2002 | 1 | 37 | 38 |
| 2003 | 0 | 38 | 38 |
| 2004 | 1 | 58 | 59 |
| 2005 | 0 | 63 | 63 |
| 2006 | 0 | 67 | 67 |
| 2007 | 1 | 79 | 80 |
| 2008 | 0 | 85 | 85 |
| 2009 | 0 | 88 | 88 |
| 2010 | 1 | 66 | 67 |
| 2011 | 0 | 87 | 87 |
| 2012 | 0 | 104 | 104 |
| 2013 | 0 | 82 | 82 |
| 2014 | 0 | 91 | 91 |
| 2015 | 0 | 80 | 80 |
| 2016 | 0 | 90 | 90 |
| 2017 | 0 | 58 | 58 |
| 2018 | 0 | 62 | 62 |
| 2019 | 0 | 65 | 65 |
| 2020 | 0 | 57 | 57 |
| 2021 | 0 | 41 | 41 |
| 2022 | 0 | 15 | 15 |
| 2023 | 1 | 10 | 11 |
| 2024 | 11 | 11 | 22 |
| 2025 | 0 | 32 | 32 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mice, Knockout" by people in Profiles.
-
Racine JJ, Dwyer JR, Chapman HD, Bell A, Robledo RF, Serreze DV. Direct-in-NOD genetic ablation of Bcl3 leads to complete type 1 diabetes protection. J Immunol. 2025 Nov 01; 214(11):2847-2860.
-
de Souza Silva L, Monks BG, Forconi CS, Crabtree JN, De Paula Tamburro N, Kurt-Jones EA, Gazzinelli RT, Fitzgerald KA, Golenbock DT. Interleukin-10 limits immune-mediated pathology in chronic subclinical plasmodial infection. PLoS Negl Trop Dis. 2025 Sep; 19(9):e0013554.
-
Cashman TJ, Saheera S, Blau AE, Mensah Otabil E, Nagy NY, Samenuk TD, Fitzgibbons TP, McManus DD, Trivedi CM. Epigenetic dysregulation of energy homeostasis drives aortic valve stenosis that is treatable with metformin. JCI Insight. 2025 Sep 09; 10(17).
-
Welton JM, Tremblay KD, Mager J. Loss of CMTR1 leads to gastrulation failure and early embryonic lethality. Dev Biol. 2025 Dec; 528:1-12.
-
Megathlin HR, Burzenski L, Brehm MA, Greiner DL, Balu-Iyer S, Shultz LD. Increased longevity of circulating human IgG in an NSG Fc gamma receptor-1 deficient humanized mouse model. J Pharm Sci. 2025 Oct; 114(10):103964.
-
Agrawal A, Ngwa DN, Simons JP, Singh SK. Protection against prolonged pneumococcal infection involves structural changes in C-reactive protein and subsequent binding to both phosphocholine and amyloids on the bacterial surface. Front Immunol. 2025; 16:1631409.
-
Mohamed MR, Zhao G, Volkert I, Molinaro A, Schneider CV, Strnad P, Hengstler JG, Xu C, Davis RJ, Schneider KM, Cubero FJ, Trautwein C. Differential Protective Roles of c-Jun N-terminal Kinase-2 in Nonparenchymal Liver Cells and Hepatocytes During Cholestasis. Cell Mol Gastroenterol Hepatol. 2025; 19(11):101588.
-
Ehrlich AM, MacGregor KA, Ashcroft SP, Small L, Altintas A, Chibalin AV, Anagho-Mattanovich M, Stocks B, Moritz T, Treebak JT, Zierath JR. HIF1a mediates circadian regulation of skeletal muscle metabolism and substrate preference in response to time-of-day exercise. Proc Natl Acad Sci U S A. 2025 Jul 15; 122(28):e2504080122.
-
Zhang F, Wang Y, Zhang L, Wang C, Chen D, Liu H, Xu R, Haynes CM, Shim JH, Ge X. The ESCRT protein CHMP5 restricts bone formation by controlling endolysosome-mitochondrion-mediated cell senescence. Elife. 2025 Jul 07; 13.
-
Feng HZ, Strauss KA, Jin JP. Potential cytotoxicity of truncated slow skeletal muscle troponin T (ssTnT) in a loss of function TNNT1 myopathy mouse model. FEBS J. 2025 Oct; 292(20):5525-5539.